Avoiding Losses Under CMS TEAM and CJR-X: Managing Risk at the Point of Care

About this Session

TEAM’s no-downside glide path ends January 1, 2027, and CJR-X extends mandatory 90-day joint replacement episodes to 2,000+ hospitals in 2028, with quality as a gate on payment. In this 35-minute session, health system leaders will learn why episode losses are decided at the bedside and cannot wait for the reconciliation report, and how predictive medicine puts patient-level risk, its causes, and the next action in front of surgeons and care managers while there is still time to act.

What We'll Cover:

• TEAM and CJR-X side by side

• Where things break (readmission, post-acute overrun, ED use, complications) and why retrospective review arrives too late

• What predictive medicine changes: a probability, the reasons, and an action for the specific patient who will break the episode

• A walk through all TEAM episodes and the CJR-X 90-day window and where to start today

• How to generate returns — the drivers, the sensitivities, and how to test them on your own historical episodes

Webinar Speakers

Dr. Rich Gliklich, Founder, OM1

Dr. Richard Gliklich, MD is the founder of OM1 and brings decades of experience in the areas of registries, outcomes, and analytics. He is senior editor of the landmark publication by the U.S. Agency for Healthcare Research and Quality (AHRQ) handbook "Registries for Evaluating Patient Outcomes: A User's Guide” and the PI for the Outcomes Measures Framework, which focuses on standardization of outcomes measurement. He has led several key national and international efforts focused on evaluating the safety, effectiveness, value and quality of healthcare. Dr. Gliklich also holds several patents for both health outcomes systems and medical devices.